Get started
Live feed
·
INSIDERFilingvia Quantisnow
Corcept Therapeutics Incorporated logo

Chief Development Officer Guyer William was granted 1,754 shares, increasing direct ownership by 79% to 3,985 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Corcept Therapeutics Incorporated logo
CORT
Corcept Therapeutics Incorporated
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2004
Follow CORTFull CORT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CORT (Corcept Therapeutics Incorporated) and more on Quantisnow.